4.7 Article

Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons

Journal

JOURNAL OF NEUROSCIENCE
Volume 41, Issue 19, Pages 4335-4348

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.2590-20.2021

Keywords

iPSC; MAPT; Alzheimer's disease; FTLD; tau seeding; tau aggregation; neurotoxicity; PSEN1 L435F

Categories

Funding

  1. Alzheimer's Association Clinician Scientist Fellowship [2018-AASCF-592307]
  2. Jack Satter Foundation Award
  3. Dr. and Mrs. E. P. Richardson, Jr Fund for Neuropathology at Massachusetts General Hospital
  4. National Institute on Aging [P30AG062421]
  5. Cure Alzheimer Fund
  6. National Institutes of Health (NIH) [1R01-AG-058002-01]
  7. Alzheimer's Association [2018-AARF-591935]
  8. Martin L. and Sylvia Seevak Hoffman Fellowship for Alzheimer's Research
  9. Massachusetts Alzheimer's Disease Research Center (NIH) [1P30-AG-062421-01]
  10. Ricardo Dolmesch at the Novartis Institutes for BioMedical Research (Boston, MA)

Ask authors/readers for more resources

This study established an accelerated human neuronal model incorporating soluble tau species and tau aggregation, and showed that uptake of exogenous tau seeds increases the risk of neuronal death. Specific morphologic strains of Tau aggregation were identified to be associated with differing levels of neurotoxicity. Additionally, iPSC neurons expressing the PSEN1 L435F mutation exhibited accelerated Tau aggregation kinetics and a bias in tau strain propagation.
Tau aggregation within neurons is a critical feature of Alzheimer's disease (AD) and related tauopathies. It is believed that soluble pathologic tau species seed the formation of tau aggregates in a prion-like manner and propagate through connected neurons during the progression of disease. Both soluble and aggregated forms of tau are thought to have neurotoxic properties. In addition, different strains of misfolded tau may cause differential neurotoxicity. In this work, we present an accelerated human neuronal model of tau-induced neurotoxicity that incorporates both soluble tau species and tau aggregation. Using patient-derived induced pluripotent stem cell (iPSC) neurons expressing a tau aggregation biosensor, we develop a cell culture system that allows continuous assessment of both induced tau aggregation and neuronal viability at single-cell resolution for periods of >1 week. We show that exogenous tau seed uptake, as measured by tau repeat domain (TauRD) reporter aggregation, increases the risk for subsequent neuronal death in vitro. These results are the first to directly visualize neuronal TauRD aggregation and subsequent cell death in single human iPSC neurons. Specific morphologic strains or patterns of TauRD aggregation are then identified and associated with differing neurotoxicity. Furthermore, we demonstrate that familial AD iPSC neurons expressing the PSEN1 L435F mutation exhibit accelerated TauRD aggregation kinetics and a tau strain propagation bias when compared with control iPSC neurons.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available